43 related articles for article (PubMed ID: 12966924)
1. Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin.
Liu XY; Wei DK; Li ZY; Lu JS; Xie XM; Yu YZ; Pang XB
Vaccine; 2023 Nov; 41(46):6834-6841. PubMed ID: 37816654
[TBL] [Abstract][Full Text] [Related]
2. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.
Robinson K; Chamberlain LM; Lopez MC; Rush CM; Marcotte H; Le Page RW; Wells JM
Infect Immun; 2004 May; 72(5):2753-61. PubMed ID: 15102785
[TBL] [Abstract][Full Text] [Related]
3. Clostridium Tetani Bacteremia From a Suspected Cutaneous Source.
Kazadi D; Zychowski D; Skipper C; Teravskis P; Hansen GT; Ordaya EE
Cureus; 2022 Mar; 14(3):e22848. PubMed ID: 35382192
[TBL] [Abstract][Full Text] [Related]
4. [Production and immunogenicity analysis of conformation-stable fragment-C mutant of tetanus toxin].
Yu R; Hou L; Liu S; Yu C; Zhang X; Liu Y; Chen W
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):226-32. PubMed ID: 21650047
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
Yu R; Hou L; Yu C; Liu S; Ren J; Fang T; Zhang X; Chen W
Immunobiology; 2011 Apr; 216(4):485-90. PubMed ID: 20888666
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.
Yu YZ; Gong ZW; Ma Y; Zhang SM; Zhu HQ; Wang WB; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2011 Aug; 29(35):5978-85. PubMed ID: 21718736
[TBL] [Abstract][Full Text] [Related]
7. Generation of plant-derived recombinant DTP subunit vaccine.
Brodzik R; Spitsin S; Pogrebnyak N; Bandurska K; Portocarrero C; Andryszak K; Koprowski H; Golovkin M
Vaccine; 2009 Jun; 27(28):3730-4. PubMed ID: 19464556
[TBL] [Abstract][Full Text] [Related]
8. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
[TBL] [Abstract][Full Text] [Related]
9. [Production of recombinant fragments of the Clostridium tetani neurotoxin for the development of new immune-prophylaxis preparations against tetanus].
Varfolomeeva NA; Makhotina OA; Sergeeva TI; Belyĭ IuF
Mol Gen Mikrobiol Virusol; 2003; (3):29-33. PubMed ID: 12966924
[TBL] [Abstract][Full Text] [Related]
10. New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC.
Tregoning J; Maliga P; Dougan G; Nixon PJ
Phytochemistry; 2004 Apr; 65(8):989-94. PubMed ID: 15110679
[TBL] [Abstract][Full Text] [Related]
11. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
Stevenson FK; Rice J; Ottensmeier CH; Thirdborough SM; Zhu D
Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
